Literature DB >> 12890855

Profile of specific antibodies to the SARS-associated coronavirus.

Gang Li, Xuejuan Chen, Anlong Xu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12890855     DOI： 10.1056/NEJM200307313490520

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  145 in total

Review 1.  Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic.

Authors:  Roy M Anderson; Christophe Fraser; Azra C Ghani; Christl A Donnelly; Steven Riley; Neil M Ferguson; Gabriel M Leung; T H Lam; Anthony J Hedley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

2.  Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography.

Authors:  Chunyan Zhang; Lei Zhou; Kang Du; Ying Zhang; Jing Wang; Lijuan Chen; Yanning Lyu; Jun Li; Hao Liu; Junli Huo; Fei Li; Jiayi Wang; Peipei Sang; Si Lin; Yi Xiao; Kan Zhang; Kunlun He
Journal:  Front Cell Infect Microbiol       Date:  2020-11-30       Impact factor: 5.293

3.  Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay.

Authors:  Fuxun Yu; Mai Quynh Le; Shingo Inoue; Hong Thi Cam Thai; Futoshi Hasebe; Maria Del Carmen Parquet; Kouichi Morita
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

4.  Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.

Authors:  Edward N van den Brink; Jan Ter Meulen; Freek Cox; Mandy A C Jongeneelen; Alexandra Thijsse; Mark Throsby; Wilfred E Marissen; Pauline M L Rood; Alexander B H Bakker; Hans R Gelderblom; Byron E Martina; Albert D M E Osterhaus; Wolfgang Preiser; Hans Wilhelm Doerr; John de Kruif; Jaap Goudsmit
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.

Authors:  Litao Yang; Hui Peng; Zhaoling Zhu; Gang Li; Zitong Huang; Zhixin Zhao; Richard A Koup; Robert T Bailer; Changyou Wu
Journal:  J Gen Virol       Date:  2007-10       Impact factor: 3.891

6.  The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.

Authors:  Susan E Richardson; Raymond Tellier; James Mahony
Journal:  Clin Biochem Rev       Date:  2004-05

7.  Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.

Authors:  Liqun Lu; Ivanus Manopo; Bernard P Leung; Hiok Hee Chng; Ai Ee Ling; Li Lian Chee; Eng Eong Ooi; Shzu-Wei Chan; Jimmy Kwang
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.

Authors:  Patrick C Y Woo; Susanna K P Lau; Beatrice H L Wong; Kwok-hung Chan; Chung-ming Chu; Hoi-wah Tsoi; Yi Huang; J S Malik Peiris; Kwok-yung Yuen
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS.

Authors:  Zhongping He; Qingming Dong; Hui Zhuang; Shujing Song; Guoai Peng; Guangxiang Luo; Dominic E Dwyer
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

10.  Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups.

Authors:  G M Leung; W W Lim; L-M Ho; T-H Lam; A C Ghani; C A Donnelly; C Fraser; S Riley; N M Ferguson; R M Anderson; A J Hedley
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.